Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use MINOCYCLINE HYDROCHLORIDE EXTENDED-RELEASE TABLETS safely and effectively. See full prescribing information for MINOCYCLINE HYDROCHLORIDE EXTENDED-RELEASE TABLETS. MINOCYCLINE HYDROCHLORIDE extended-release tablets, for oral use Initial U.S. Approval: 1971
Medication labelWhy this: Advisory · dailymed-prescription
Minocycline hydrochloride extended-release tablets are indicated to treat inflammatory lesions of non-nodular moderate to severe acne vulgaris in patients 12 years of age and older. Limitations of Use Minocycline hydrochloride extended-release tablets did not demonstrate any effect on non-inflammatory acne lesions. This formulation of minocycline has not been evaluated in the treatment of infections [see Clinical Studies (14)]. To reduce the development of drug-resistant bacteria as well as to maintain the effectiveness of other antibacterial drugs, use minocycline hydrochloride extended-release tablets only as indicated [see Warnings and Precautions (5.12)].
- generic_name
- minocycline hydrochloride
- product_names
- Minocycline Hydrochloride
- ndc
- 65862-554, 65862-555, 65862-556, 65862-557, 65862-558, 65862-883, 65862-884, 65862-885, 65862-554-30, 65862-554-01, 65862-554-99, 65862-883-30, 65862-883-01, 65862-883-05, 65862-883-99, 65862-555-30, 65862-555-99, 65862-884-30, 65862-884-01, 65862-884-05, 65862-884-99, 65862-556-30, 65862-556-01, 65862-556-99, 65862-885-30, 65862-885-01, 65862-885-05, 65862-885-99, 65862-557-30, 65862-557-99, 65862-558-30, 65862-558-01, 65862-558-99
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en